Iocarmic acid: Difference between revisions
Appearance
Content deleted Content added
No edit summary |
Michael7604 (talk | contribs) recategorized from Iodoarenes to Iodobenzene derivatives |
||
(28 intermediate revisions by 18 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
| verifiedrevid = 407427669 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| alt = Skeletal formula of iocarmic acid |
|||
⚫ | |||
| width = 260 |
|||
⚫ | |||
| image2 = Iocarmic-acid-3D-spacefill.png |
|||
⚫ | |||
| alt2 = Space-filling model of the iocarmic acid molecule |
|||
⚫ | |||
⚫ | |||
<!--Clinical data--> |
|||
| molecular_weight = 1253.86 g/mol |
|||
| tradename = Dimer-X |
|||
⚫ | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|||
⚫ | |||
| pregnancy_US = <!-- A / B / C / D / X --> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
||
| |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
|||
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
|||
⚫ | |||
⚫ | |||
| routes_of_administration = |
| routes_of_administration = |
||
<!--Pharmacokinetic data--> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Identifiers--> |
|||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
⚫ | |||
| UNII_Ref = {{fdacite|changed|FDA}} |
|||
| UNII = 82PB24K6TZ |
|||
| KEGG_Ref = {{keggcite|correct|kegg}} |
|||
⚫ | |||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = 23564 |
|||
<!--Chemical data--> |
|||
⚫ | |||
⚫ | |||
| smiles = CNC(=O)c1c(c(c(c(c1I)NC(=O)CCCCC(=O)Nc2c(c(c(c(c2I)C(=O)O)I)C(=O)NC)I)I)C(=O)O)I |
|||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C24H20I6N4O8/c1-31-21(37)9-13(25)11(23(39)40)17(29)19(15(9)27)33-7(35)5-3-4-6-8(36)34-20-16(28)10(22(38)32-2)14(26)12(18(20)30)24(41)42/h3-6H2,1-2H3,(H,31,37)(H,32,38)(H,33,35)(H,34,36)(H,39,40)(H,41,42) |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChIKey = SMQYOVYWPWASGU-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''Iocarmic acid''' (trade name '''Dimer-X''') is a pharmaceutical drug used as an [[iodinated contrast]] medium for X-ray imaging in the 1970s and 80s. Uses included imaging of the [[uterus]] and [[fallopian tube]]s. It was applied in form of its salt, [[meglumine]] iocarmate.<ref>{{cite journal | vauthors = Schütte HE | title = Comparative study: Endografine (diatrizoate), Vasurix polyvidone (acetrizoate), Dimer-X (iocarmate) and Hexabrix (ioxaglate) in hysterosalpingography | journal = Diagnostic Imaging | volume = 51 | issue = 6 | pages = 277–83 | year = 1982 | pmid = 7173007 }}</ref><ref>{{cite journal | vauthors = Van Dellen JR, Lipschitz R | title = Meglumine iocarmate (Dimer-X) ventriculography | journal = Clinical Radiology | volume = 24 | issue = 4 | pages = 449–52 | date = October 1973 | pmid = 4621055 | doi = 10.1016/s0009-9260(73)80146-1 }}</ref> |
|||
'''Iocarmic acid''' is a molecule used as a [[contrast medium]]. |
|||
It is not known to be marketed anywhere in the world in 2021. |
|||
== References == |
|||
⚫ | |||
{{reflist}} |
|||
{{Contrast media}} |
{{Contrast media}} |
||
[[Category:Radiocontrast agents]] |
[[Category:Radiocontrast agents]] |
||
[[Category: |
[[Category:Iodobenzene derivatives]] |
||
[[Category:Benzoic acids]] |
[[Category:Benzoic acids]] |
||
[[Category:Benzamides]] |
[[Category:Benzamides]] |
||
[[Category:Anilides]] |
[[Category:Anilides]] |
||
⚫ |